Extrapyramidal Side Effects in a Patient with Alcohol Withdrawal Symptoms: A Reflection of Quality of the Mental Health Care System

References

• Abu-Naser D, Gharaibeh S, Al Meslamani AZ, Alefan Q, Abunaser R. Assessment of extrapyramidal symptoms associated with psychotropics pharmacological treatments, and associated risk factors. Clin Pract Epidemiol Mental Health. 2021;17:1. doi:10.2174/1745017902117010001
   Google Scholar
• D’Souza RS, Hooten WM. Extrapyramidal Symptoms. StatPearls [Internet]; 2020.
   Google Scholar
• Li HC, Luo KX, Wang JS, Wang QX. Extrapyramidal side effect of donepezil hydrochloride in an elderly patient: a case report. Medicine. 2020;99(11).
   Web of Science ®Google Scholar
• Pierre JM. Abuse of psychiatric medications: not just stimulants and benzodiazepines. Curr Psychiatr. 2019;18(1):11.
   Google Scholar
• Hedenmalm K, Güzey C, Dahl ML, Yue QY, Spigset O. Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms. J Clin Psychopharmacol. 2006;26(2):192–197. doi:10.1097/01.jcp.0000203200.96205.34
   PubMed Web of Science ®Google Scholar
• Dayalu P, Chou KL. Antipsychotic-induced extrapyramidal symptoms and their management. Expert Opin Pharmacother. 2008;9(9):1451–1462. doi:10.1517/14656566.9.9.1451
   PubMed Web of Science ®Google Scholar
• Kigozi F, Ssebunnya J, Kizza D, Cooper S, Ndyanabangi S. An overview of Uganda’s mental health care system: results from an assessment using the world health organization’s assessment instrument for mental health systems (WHO-AIMS). Int J Ment Health Syst. 2010;4(1):1–9. doi:10.1186/1752-4458-4-1
   PubMed Web of Science ®Google Scholar
• Kamwesiga J. Uganda Health Care System. Kampala, Uganda: Makerere University; 2011.
   Google Scholar
• Chouinard G, Margolese HC. Manual for the extrapyramidal symptom rating scale (ESRS). Schizophr Res. 2005;76(2–3):247–265. doi:10.1016/j.schres.2005.02.013
   PubMed Web of Science ®Google Scholar
• Carvalho AF, Heilig M, Perez A, Probst C, Rehm J. Alcohol use disorders. Lancet. 2019;394(10200):781–792. doi:10.1016/S0140-6736(19)31775-1
   PubMed Web of Science ®Google Scholar
• Rehm J, Shield KD. Global burden of disease and the impact of mental and addictive disorders. Curr Psychiatry Rep. 2019;21(2):1–7. doi:10.1007/s11920-019-0997-0
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Status Report on Road Safety 2015. World Health Organization; 2015.
   Google Scholar
• Tumwesigye NM, Kasirye R, Nansubuga E. Is social interaction associated with alcohol consumption in Uganda? Drug Alcohol Depend. 2009;103(1–2):9–15. doi:10.1016/j.drugalcdep.2009.01.016
   Web of Science ®Google Scholar
• Kabwama SN, Ndyanabangi S, Mutungi G, Wesonga R, Bahendeka SK, Guwatudde D. Alcohol use among adults in Uganda: findings from the countrywide non-communicable diseases risk factor cross-sectional survey. Glob Health Action. 2016;9(1):31302. doi:10.3402/gha.v9.31302
   PubMed Web of Science ®Google Scholar
• Wise RA, Robble MA. Dopamine and addiction. Ann Rev Psychol. 2020;71:79–106. doi:10.1146/annurev-psych-010418-103337
   PubMed Web of Science ®Google Scholar
• Noble EP. Addiction and its reward process through polymorphisms of the D 2 dopamine receptor gene: a review. Eur Psychiatry. 2000;15(2):79–89. doi:10.1016/S0924-9338(00)00208-X
   Web of Science ®Google Scholar
• American Psychiatric Association, A. P., & American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5; 2013.
   Google Scholar
• Farrokh S, Roels C, Owusu KA, Nelson SE, Cook AM. Alcohol withdrawal syndrome in neurocritical care unit: assessment and treatment challenges. Neurocrit Care. 2020:1–15.
   Web of Science ®Google Scholar
• Stankewicz HA, Richards JR, Salen P. Alcohol Related Psychosis. StatPearls [Internet]; 2020.
   Google Scholar
• Kapur S, Zipursky R, Jones C, Remington G, Houle S. Relationship between dopamine D2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry. 2000;157(4):514–520. doi:10.1176/appi.ajp.157.4.514
   PubMed Web of Science ®Google Scholar
• Potvin S, Blanchet P, Stip E. Substance abuse is associated with increased extrapyramidal symptoms in schizophrenia: a meta-analysis. Schizophr Res. 2009;113(2–3):181–188. doi:10.1016/j.schres.2009.06.010
   Web of Science ®Google Scholar
• De Maio D, Caponeri MA, Cicchetti V, Mellado C, Scieghi G. Sulpiride and extrapyramidal syndromes in chronic heroin addiction. Neuropsychobiology. 1978;4(1):36–39. doi:10.1159/000117618
   Web of Science ®Google Scholar
• Lundh H, Tunving K. An extrapyramidal choreiform syndrome caused by amphetamine addiction. J Neurol Neurosurg Psychiatry. 1981;44(8):728–730. doi:10.1136/jnnp.44.8.728
   Web of Science ®Google Scholar
• Temmingh HS, van den Brink W, Howells F, Sibeko G, Stein DJ. Methamphetamine use and antipsychotic-related extrapyramidal side-effects in patients with psychotic disorders. J Dual Diagn. 2020;16(2):208–217. doi:10.1080/15504263.2020.1714099
   PubMed Web of Science ®Google Scholar
• Mann SK, Marwaha R. Chlorpromazine. StatPearls; 2019.
   Google Scholar
• Griffiths MD, Demetrovics Z, Atroszko PA. Ten myths about work addiction. J Behav Addict. 2018;7(4):845–857. doi:10.1556/2006.7.2018.05
   PubMed Web of Science ®Google Scholar
• Kaggwa MM. Simplifying Addiction. Subst Abuse Rehabil. 2021;Volume 12:23–26. doi:10.2147/SAR.S307387
   Web of Science ®Google Scholar
• Inanambrastate T. The effect of aversion therapy on students’attitude. GSJ. 2019;7(9).
   Google Scholar
• Kiyingi M, Bongomin F, Kizito M, Kaddumukasa M. Neuroleptic malignant syndrome: early diagnosis saves lives in low-resource settings. Int Med Case Rep J. 2020;13:359. doi:10.2147/IMCRJ.S270332
   Web of Science ®Google Scholar
• Caffrey D, Sowden GL. A missed case of lurasidone induced laryngospasm: a case study and overview of extrapyramidal symptom identification and treatment. Int J Psychiatry Med. 2020;0091217420943786. doi:10.1177/0091217420943786
   Web of Science ®Google Scholar
• Berman BD. Neuroleptic malignant syndrome: a review for neurohospitalists. Neurohospitalist. 2011;1(1):41–47. doi:10.1177/1941875210386491
   Google Scholar
• Dose M, Tempel HD. Abuse potential of anticholinergics. Pharmacopsychiatry. 2000;33(Sup.1):43–46. doi:10.1055/s-2000-7583
   Web of Science ®Google Scholar
• Rubinstein JS. Abuse of antiparkinsonism drugs: feigning of extrapyramidal symptoms to obtain trihexyphenidyl. JAMA. 1978;239(22):2365–2366. doi:10.1001/jama.239.22.2365
   Web of Science ®Google Scholar
• De La Villarmois EA, Constantin MF, Pérez MF. From benzodiazepine prescription to dependence: learning processes Involved. In: Gargiulo PÁ, Mesones Arroyo HL, editors. Psychiatry and Neuroscience Update. Cham: Springer; 2021:213–236.
   Google Scholar
• Pringsheim T, Doja A, Belanger S, Patten S; Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) guideline group. Treatment recommendations for extrapyramidal side effects associated with second-generation antipsychotic use in children and youth. Paediatr Child Health. 2011;16(9):590–598. doi:10.1093/pch/16.9.590
   PubMed Web of Science ®Google Scholar